(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) jumped by a staggering 17.06% in 7 days from $6.33 to $7.41 at 11:11 EST on Sunday, after three sequential sessions in a row of gains. NASDAQ Composite is jumping 1% to $15,860.96, after two consecutive sessions in a row of gains.

Catalyst Pharmaceuticals’s last close was $7.41, 1.23% higher than its 52-week high of $7.32.


Today’s last reported volume for Catalyst Pharmaceuticals is 2085013 which is 138.21% above its average volume of 875260.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the present quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was 0.71%, 0.14%, and 2.28%, respectively.

Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.32% (last week), 1.82% (last month), and 2.28% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $7.41 at 11:11 EST, higher than its 52-week high of $7.32.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way higher than its 50-day moving average of $5.85 and way above its 200-day moving average of $5.56.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here